Leveljump Healthcare Corp. (V:JUMP)
Business Focus: Healthcare Facilities & Services (NEC)
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| Company Contact | |
| Address: | #207-52 Scarsdale Rd TORONTO ON M3B 2R7 |
| Tel: | N/A |
| Website: | N/A |
| IR: | N/A |
| Key People | ||
| N/A | ||
| Business Overview |
| LevelJump Healthcare Corp. is a Canada-based company. The Company's principal business activity is providing radiology services both by providing direct patient images and by providing Teleradiology services. Teleradiology is the process of providing remote off site reading of radiology scans such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasound (US), and X-ray. Hospital staff scan their emergency room patients, then page the Company's radiologist on call, who can then remotely view, via secured server, the images and diagnose the patient and provide a report back to the hospital. The Company focuses primarily on critical care for urgent and emergency patients. The Company provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in-person radiology services through its Independent Healthcare Facilities (IHF's). The Company operates approximately eight IHF's. |
| Financial Overview |
| For the nine months ended 30 September 2023, Leveljump Healthcare Corp revenues increased 36% to C$9M. Net loss increased from C$737K to C$2M. Revenues reflect Telehealth Services increase of 35% to C$7.2M, Admin Services increase from C$139K to C$463K, Diagnostic Imaging Services increase of 20% to C$1.3M. Higher net loss reflects Professional fees increase from C$659K to C$1.8M (expense). |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $11.32M as of Sep 30, 2023 |
| Annual revenue (TTM): | $11.63M as of Sep 30, 2023 |
| EBITDA (TTM): | -$0.13M as of Sep 30, 2023 |
| Net annual income (TTM): | -$1.06M as of Sep 30, 2023 |
| Free cash flow (TTM): | -$1.05M as of Sep 30, 2023 |
| Net Debt Last Fiscal Year: | $4.24M as of Sep 30, 2023 |
| Shares outstanding: | 96,484,729 as of Jan 18, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
